These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2577407)

  • 1. Comparative study of two different routes for insulin administration in CAPD diabetic patients. A multicenter study.
    Selgas R; Diez JJ; Muñoz J; Miranda B; de Alvaro F; Rodriguez JC
    Adv Perit Dial; 1989; 5():181-4. PubMed ID: 2577407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous ambulatory peritoneal dialysis in diabetes mellitus. The risks and benefits of intraperitoneal insulin.
    Madden MA; Zimmerman SW; Simpson DP
    Am J Nephrol; 1982; 2(3):133-9. PubMed ID: 6758585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin therapy in uremic diabetic patients on continuous ambulatory peritoneal dialysis; comparison of intraperitoneal and subcutaneous administration.
    Scarpioni L; Ballocchi S; Castelli A; Scarpioni R
    Perit Dial Int; 1994; 14(2):127-31. PubMed ID: 8043664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of glycemic control by CAPD with intraperitoneal insulin in a child with IDDM and ESRD.
    Flynn JT; Kershaw DB; Sedman AB; Smoyer WE; Bunchman TE
    Adv Perit Dial; 1998; 14():265-8. PubMed ID: 10649738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous versus intraperitoneal insulin in the management of diabetics on CAPD: a review.
    Tzamaloukas AH; Oreopoulos DG
    Adv Perit Dial; 1991; 7():81-5. PubMed ID: 1680463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous versus intraperitoneal insulin for patients with diabetes mellitus on continuous ambulatory peritoneal dialysis: meta-analysis of non-randomized clinical trials.
    Almalki MH; Altuwaijri MA; Almehthel MS; Sirrs SM; Singh RS
    Clin Invest Med; 2012 Jun; 35(3):E132-43. PubMed ID: 22673316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic subcapsular steatosis as a complication associated with intraperitoneal insulin treatment in diabetic peritoneal dialysis patients.
    Torun D; Oguzkurt L; Sezer S; Zumrutdal A; Singan M; Adam FU; Ozdemir FN; Haberal M
    Perit Dial Int; 2005; 25(6):596-600. PubMed ID: 16411528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients.
    Nevalainen P; Lahtela JT; Mustonen J; Pasternack A
    Nephrol Dial Transplant; 1997 Jan; 12(1):145-50. PubMed ID: 9027790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of insulin by continuous ambulatory peritoneal dialysis.
    Chan E; Montgomery PA
    Pharmacotherapy; 1993; 13(5):455-60. PubMed ID: 8247911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreasing insulin requirements in CAPD patients given intraperitoneal insulin.
    Grefberg N; Danielson BG; Berne C
    J Diabet Complications; 1987; 1(1):16-9. PubMed ID: 2968990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous ambulatory peritoneal dialysis in diabetics with end-stage renal disease.
    Amair P; Khanna R; Leibel B; Pierratos A; Vas S; Meema E; Blair G; Chisolm L; Vas M; Zingg W; Digenis G; Oreopoulos D
    N Engl J Med; 1982 Mar; 306(11):625-30. PubMed ID: 7035945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous ambulatory peritoneal dialysis in diabetic patients with end-stage renal disease: experience with intraperitoneal insulin therapy.
    Chen HC; Lai YH; Tsai CY; Shin SJ; Tsai JH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Feb; 7(2):56-61. PubMed ID: 2005672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood glucose and cholesterol control improved by continuous ambulatory peritoneal dialysis in patients with end-stage renal disease and diabetes mellitus.
    Wikdahl AM; Granbom L; Sörensen JG; Stegmayr BG
    Perit Dial Int; 1993; 13 Suppl 2():S239-41. PubMed ID: 8399577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advisability of switching of i.p. insulin in to CAPD.
    Quellhorst E
    Semin Dial; 2002; 15(5):376. PubMed ID: 12358646
    [No Abstract]   [Full Text] [Related]  

  • 15. Continuous ambulatory peritoneal dialysis in the treatment of end-stage diabetic nephropathy.
    Grefberg N; Danielson BG; Nilsson P
    Acta Med Scand; 1984; 215(5):427-34. PubMed ID: 6377827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of peritonitis on insulin and glucose absorption during peritoneal dialysis in diabetic rats.
    Mactier RA; Moore H; Khanna R; Shah J
    Nephron; 1990; 54(3):240-4. PubMed ID: 2179758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal insulin for control of glucose level in insulin dependent diabetic patients treated by CAPD.
    Rottembourg J; Balducci A; Baumelou A; Jacq D; Agrafiotis A; Slama G
    Proc Clin Dial Transplant Forum; 1980; 10():305-7. PubMed ID: 7050993
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration.
    Quellhorst E
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S92-6. PubMed ID: 11792768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraperitoneal insulin in diabetic CAPD patients.
    Mactier RA; Khanna R
    Int J Artif Organs; 1988 Jan; 11(1):9-12. PubMed ID: 3283057
    [No Abstract]   [Full Text] [Related]  

  • 20. [Continuous ambulatory peritoneal dialysis in diabetic patients].
    Stojimrović B; Nesić V
    Srp Arh Celok Lek; 1998; 126(7-8):277-82. PubMed ID: 9863395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.